Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Paracervical block for pain control after vNOTES uterosacral ligament suspension

Official title: A Prospective Randomized Double-Blind Placebo-Controlled Trial Evaluating the Effect of Paracervical Block on Postoperative Pain After vNOTES Uterosacral Ligament Suspension

Run by Bakirkoy Dr. Sadi Konuk Research and Training Hospital · NCT07440576 · Data updated 2026-11-12

This will test whether a paracervical injection of bupivacaine reduces early postoperative pain in women having vNOTES uterosacral ligament suspension for pelvic organ prolapse.

More Pelvic Organ Prolapse (POP) trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment58 (estimated)
SponsorBakirkoy Dr. Sadi Konuk Research and Training Hospital
Government
Drugs / interventionsradiation
Locations1 site (Istanbul, Istanbul)
StatusRecruiting
StartedMarch 9, 2026
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedMarch 11, 2026
Trial IDNCT07440576 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 years or older with symptomatic pelvic organ prolapse scheduled for vNOTES uterosacral ligament suspension (with planned hysterectomy) who are ASA I–III and can give informed consent.

Probably not a fit

Patients with allergy to bupivacaine or other local anesthetics, chronic opioid use or chronic pain disorders, prior pelvic radiation, severe hepatic/renal impairment, coagulopathy or anticoagulation contraindicating injection, active pelvic infection, pregnancy, or inability to use the pain scale are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, randomized, double-blind, placebo-controlled trial in 58 patients undergoing vNOTES uterosacral ligament suspension for benign indications. Participants are randomized 1:1 to receive a 10 mL paracervical injection of 0.5% bupivacaine or 10 mL normal saline prepared and administered in a blinded fashion. The primary outcome is pain on the Visual Analog Scale at 6 hours after surgery, with additional pain measurements up to 24 hours, total analgesic consumption, length of stay, and patient satisfaction as secondary outcomes. Analyses will follow the intention-to-treat principle.

Why it matters

Potential benefit: If successful, adding a paracervical block could reduce early postoperative pelvic pain and lower short-term opioid needs after vNOTES procedures.

How similar studies have gone: Paracervical block has shown mixed results in other gynecologic procedures, and high-quality randomized data specifically for vNOTES are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female patients aged 18 years or older
* Symptomatic pelvic organ prolapse requiring uterosacral ligament suspension (USLS)
* Planned hysterectomy (vaginal hysterectomy or vNOTES hysterectomy) with concomitant BS or BSO, followed by vNOTES uterosacral ligament suspension
* ASA physical status I-III
* Ability to provide written informed consent

Exclusion Criteria:

* Known allergy or hypersensitivity to bupivacaine or local anesthetic agents
* Chronic opioid use or chronic pain disorders
* Previous pelvic radiation therapy
* Severe hepatic or renal impairment
* Coagulopathy or anticoagulant therapy contraindicating injection
* Active pelvic infection
* Pregnancy
* Inability to understand the pain scoring system

Where it's running

  • Bakirkoy Dr. Sadi Konuk Training and Research Hospital
    Istanbul, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Erkan Göl, MD — Bakirkoy Dr. Sadi Konuk Research and Training Hospital
  • Study coordinator: Erkan Göl, MD
  • Email: drerkangol@gmail.com
  • Phone: +905398517917

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.